These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 7782024)

  • 41. [Bone involvement in primary oxalosis. Study of 20 cases].
    Benhamou CL; Bardin T; Tourlière D; Voisin L; Audran M; Edouard C; Lafage MH; Sebert JL; de Vernejoul MC; Wendling D
    Rev Rhum Mal Osteoartic; 1991 Nov; 58(11):763-9. PubMed ID: 1780651
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Primary hyperoxaluria in children in central Tunisia].
    Chemli J; Abdennabi H; Zorgati M; Abdelhak S; Nabli N; Abroug S; Sfar MT; Ben Dhia N; Amri F; Harbi A
    Tunis Med; 2007 Jun; 85(6):513-8. PubMed ID: 17644908
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Polyradiculoneuropathy in an adult with primitive hyperoxaluria].
    Furby A; Mourtada R; Charasse C; Rivalan J; Messner M; Leroy JP
    Rev Neurol (Paris); 2000 Jan; 156(1):62-4. PubMed ID: 10693261
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Combined liver-kidney and kidney-alone transplantation in primary hyperoxaluria.
    Monico CG; Milliner DS
    Liver Transpl; 2001 Nov; 7(11):954-63. PubMed ID: 11699031
    [TBL] [Abstract][Full Text] [Related]  

  • 45. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The urinary response to an oral oxalate load in recurrent calcium stone formers.
    Krishnamurthy MS; Hruska KA; Chandhoke PS
    J Urol; 2003 Jun; 169(6):2030-3. PubMed ID: 12771711
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Absorptive hyperoxaluria leads to an increased risk for urolithiasis or nephrocalcinosis in cystic fibrosis.
    Hoppe B; von Unruh GE; Blank G; Rietschel E; Sidhu H; Laube N; Hesse A
    Am J Kidney Dis; 2005 Sep; 46(3):440-5. PubMed ID: 16129205
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Primary hyperoxaluria type 1 in Tunisian children.
    Gargah T; Khelil N; Gharbi Y; Karoui W; Trabelsi M; Rajhi H; Abdelmoula J; Lakhoua MR
    Tunis Med; 2011 Feb; 89(2):163-7. PubMed ID: 21308625
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Pregnancy in chronic dialysis and after renal transplantation].
    Hayashi T; Mori Y; Matsumoto S; Uemura H
    Hinyokika Kiyo; 2006 Dec; 52(12):915-7. PubMed ID: 17252972
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Among therapy modalities of end-stage renal disease, renal transplantation improves survival in patients with amyloidosis.
    Ozdemir BH; Ozdemir FN; Sezer S; Sar A; Haberal M
    Transplant Proc; 2006 Mar; 38(2):432-4. PubMed ID: 16549140
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Primary hyperoxaluria: simultaneous combined liver and kidney transplantation from a living related donor.
    Astarcioglu I; Karademir S; Gülay H; Bora S; Astarcioglu H; Kavukcu S; Türkmen M; Soylu A
    Liver Transpl; 2003 Apr; 9(4):433-6. PubMed ID: 12682898
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Primary hyperoxaluria, treated with haemodialysis and kidney transplantation.
    Jacobsen E; Mosbaek N
    Dan Med Bull; 1974 Apr; 21(2):72-6. PubMed ID: 4598252
    [No Abstract]   [Full Text] [Related]  

  • 53. [Renal replacement therapy by hemodialysis: an overview].
    Jacobs C
    Nephrol Ther; 2009 Jul; 5(4):306-12. PubMed ID: 19481513
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Outcome of end-stage renal disease in patients with rare causes of renal failure. I. Inherited and metabolic disorders.
    Nissenson AR; Port FK
    Q J Med; 1989 Nov; 73(271):1055-62. PubMed ID: 2516341
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Tuberous sclerosis with chronic renal failure treated by hemodialysis and transplantation (author's transl)].
    Meyrier A; Rainfray M; Roland J; Merlier J
    Nephrologie; 1980; 1(2):85-8. PubMed ID: 7029334
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Chronic renal failure secondary to oxalate nephropathy: a preventable complication after jejunoileal bypass.
    Hassan I; Juncos LA; Milliner DS; Sarmiento JM; Sarr MG
    Mayo Clin Proc; 2001 Jul; 76(7):758-60. PubMed ID: 11444411
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Primary hyperoxaluria type 1 causing end-stage renal disease in a 45-year-old patient.
    David-Walek T; Niederstadt C; Rob PM; Fricke L; Latta K; Steinhoff J; Stange EF
    Nephron; 2001 Jan; 87(1):80-4. PubMed ID: 11174030
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Secondary oxalosis due to excess vitamin C intake: a cause of graft loss in a renal transplant recipient.
    Yaich S; Chaabouni Y; Charfeddine K; Zaghdane S; Kharrat M; Kammoun K; Makni S; Boudawara T; Hachicha J
    Saudi J Kidney Dis Transpl; 2014 Jan; 25(1):113-6. PubMed ID: 24434393
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Bariatric surgery, calcium oxalate urinary stones and oxalate nephropathy].
    Montagnac R; Schendel A; Vuiblet V; Peilleron B; Piot O
    Nephrol Ther; 2011 Feb; 7(1):38-45. PubMed ID: 21130057
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Treatment of renal failure in the primary hyperoxalurias.
    Watts RW
    Nephron; 1990; 56(1):1-5. PubMed ID: 2234239
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.